Skip to content

Clinical trials

Carcinoma, Ovarian Epithelial trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Country / region: Singapore Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20171
20181
20191
20201
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Active, not recruiting2
Completed2
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Centre, Singapore2
Amgen1
Daiichi Sankyo1
GlaxoSmithKline1
Gynecologic Oncology Trial & Investigation Consortium1
National University Hospital, Singapore1
Novartis Pharmaceuticals1
Sutro Biopharma, Inc.1
TORL Biotherapeutics, LLC1
pharmaand GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial11
Fallopian Tube Neoplasms6
Ovarian Neoplasms5
Colorectal Neoplasms2
Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Adenocarcinoma, Clear Cell1
Anus Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.